Apyx Medical Corporation (APYX)

Apyx Medical Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	27.62	31.74	31.74	43.65	10.19	30.87
Cash & Short-Term Investments	27.62	31.74	31.74	43.65	10.19	30.87
Cash Growth	-5.75%	-0.00%	-27.29%	328.30%	-66.98%	-26.35%
Accounts Receivable	13.61	16.88	15.58	14.12	10.7	13.14
Other Receivables	-	-	-	-	7.64	8.13
Receivables	13.61	16.88	15.58	14.12	18.35	21.26
Inventory	10.75	8.6	7.56	9.92	11.8	6.78
Prepaid Expenses	1.18	1.25	1.56	2.66	2.64	1.83
Total Current Assets	53.16	58.47	56.44	70.36	42.97	60.74
Property, Plant & Equipment	6.14	6.62	6.74	7.15	7.59	6.87
Other Long-Term Assets	1.78	1.75	1.66	1.73	1.22	1.11
Total Assets	61.07	66.84	64.84	79.24	51.78	68.72

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	2.19	3.06	2.62	2.71	2.67	2.63
Accrued Expenses	3.38	4.87	3.46	5.21	3.78	6.69
Current Portion of Leases	0.47	0.43	0.36	0.37	0.25	0.29
Current Unearned Revenue	0.87	0.64	0.69	0.49	0.85	0.53
Other Current Liabilities	2.44	2.7	3.6	3.97	4.3	3.07
Total Current Liabilities	9.35	11.7	10.72	12.74	11.85	13.21
Long-Term Debt	35.33	34.85	33.89	33.19	-	-
Long-Term Leases	3.83	4.06	4.52	4.95	0.54	0.02
Long-Term Unearned Revenue	1.13	1.05	1.12	1.25	1.41	1.32
Other Long-Term Liabilities	0.34	0.35	0.26	0.2	0.18	0.17
Total Liabilities	49.98	52.01	50.51	52.32	13.98	14.71

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	0.04	0.04	0.04	0.04	0.04	0.03
Additional Paid-In Capital	105.09	103.62	92.08	81.11	73.28	66.22
Retained Earnings	-94.47	-89.12	-77.91	-54.45	-35.74	-12.55
Total Common Equity	10.66	14.54	14.21	26.7	37.58	53.7
Minority Interest	0.43	0.29	0.13	0.22	0.21	0.31
Shareholders' Equity	11.09	14.83	14.34	26.92	37.79	54.01
Total Liabilities & Equity	61.07	66.84	64.84	79.24	51.78	68.72

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	39.63	39.34	38.76	38.5	0.8	0.31
Net Cash (Debt)	-12.01	-7.6	-7.02	5.15	9.4	30.57
Net Cash Growth	-	-	-	-45.18%	-69.26%	-25.88%
Net Cash Per Share	-0.28	-0.18	-0.20	0.15	0.27	0.89
Filing Date Shares Outstanding	42.12	41.83	37.79	34.64	34.6	34.43
Total Common Shares Outstanding	42.12	41.79	37.79	34.64	34.6	34.41
Working Capital	43.8	46.77	45.72	57.62	31.12	47.53
Book Value Per Share	0.25	0.35	0.38	0.77	1.09	1.56
Tangible Book Value	10.66	14.54	14.21	26.7	37.58	53.7
Tangible Book Value Per Share	0.25	0.35	0.38	0.77	1.09	1.56
Land	-	-	-	-	1.6	1.6
Buildings	-	-	-	-	4.43	4.43
Machinery	-	6.14	5.06	4.83	5.09	5.04
Construction In Progress	-	0.16	0.64	0.4	0.51	0.65
Leasehold Improvements	-	0.36	0.28	0.21	0.18	0.17

SEC Filings: 10-K · 10-Q

Data Source: S&P Global Market Intelligence Last updated: Aug 6, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Sep 7, 2026

Data Sources Report a data error